Is the effect of intravitreal triamcinolone acetonide on diabetic macular edema dose-dependent?

European Journal of Ophthalmology

Volumn 24, Issue 2, 2013, Pages 221-227

  Šarić, Borna ^a   Šarić, Vlatka Brzović ^a   Motušić, Ranka ^a   Predović, Jurica ^a  

^a University Hospital Sveti Duh   (Croatia)

Author keywords

Diabetic retinopathy; Intraocular pressure; Intravitreal injections; Macular edema; Triamcinolone acetonide

Indexed keywords

EYE DROPS; TIMOLOL MALEATE PLUS ACETAZOLAMIDE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CENTRAL MACULAR VOLUME; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG MEGADOSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; MALE; OCULOPLETHYSMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TONOMETRY; VISUAL ACUITY;

ACETAZOLAMIDE; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DIABETIC RETINOPATHY; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; TIMOLOL; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 84892774209     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000358     Document Type: Article

References (21)

1. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002;47(Suppl 2):S253-62.
2. Giani A, Cigada M, Choudhry N, et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol 2010;150:815-24.
3. Synek S, Vojniković B. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema. Coll Antropol 2010;34(Suppl 2):99-103.
4. Giusti C, Forte R, Vingolo EM, Gargiulo P. Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. Int Ophthalmol 2001;24:79-88.
5. Doi N, Sakamoto T, Sonoda Y, et al. Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes. Graefes Arch Clin Exp Ophthalmol 2012;250:71-8.
6. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005;140:695-702.
7. Cheung N, Connell P, Wong TY. Vitrectomy for diabetic macular edema. Ophthalmology 2010;117:2235-6.
8. Sobaci G, Ozge G, Erdurman C, Durukan HA, Bayraktar ZM. Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema. Ophthalmologica 2012;227:95-9.
9. Abe T, Hayasaka S, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y. Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone. J Cataract Refract Surg 1999;25:1286-8.
10. Miyamoto N, Iossifov D, Metge F, Behar-Cohen F. Early effects of intravitreal triamcinolone on macular edema: mechanistic implication. Ophthalmology 2006;113:2048-53.
11. Bae JS, Park SJ, Ham IR, Lee TG. Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema. Korean J Ophthalmol 2009;23:80-5.
12. Diabetic Retinopathy Clinical Research N. A randomized trial comparing intravitreal triamcinolone acetonide and focal/ grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-9.
13. Jonas JB. Intravitreal triamcinolone acetonide for diabetic retinopathy. Dev Ophthalmol 2007;39:96-110.
14. Batioǧlu F, Ozmert E, Parmak N, Celik S. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. Int Ophthalmol 2007;27:299-306.
15. Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol 2010;21:178-83.
16. Dwinger MC, Pieper-Bodeewes I, Eter N, Holz FG. [Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection.] Klin Monatsbl Augenheilkd 2005;222:638-42.
17. Jonas JB, Akkoyun I, Kreissig I, Degenring RF. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study. Br J Ophthalmol 2005;89:321-6.
18. Chang W, Chung M. Efficacy of anterior chamber paracentesis after intravitreal triamcinolone injection. Eur J Ophthalmol 2007;17:776-9.
19. Lin JM, Tsai YY, Chiu YT, Hung PT. Paracentesis before or after intravitreal injection of triamcinolone acetonide and its necessity? Am J Ophthalmol 2006;141:985-6author reply 986.
20. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB III, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-6.
21. Spandau UH, Derse M, Schmitz-Valckenberg P, Papoulis C, Jonas JB. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. Br J Ophthalmol 2005;89:999-1003.